Seizure medications are developed to treat different types of seizures. We learn more about medicines after a drug has been available for a while and used in larger numbers of people.Yet, it is often hard to know which drugs may be best for different types of epilepsy and how they compare to one another.
Guidelines have been developed by the American Epilepsy Society (AES) and the American Academy of Neurology (AAN) to help health care professionals understand published research findings on the use of the newer seizure medicines. These guidelines summarize the use of newer seizure medicines for people newly diagnosed with seizures and for those with refractory seizures (seizures that have not been successfully controlled by medication). A third guideline summarizes information on available treatments for refractory epilepsy. These guidelines do not give information about the use of the older seizure medicines or include newer research published since the guidelines were made.
- A summary of the practice guidelines on the use of newer seizure medicines in New Onset Epilepsy
- A summary of the practice guideline on the use of the newer seizure medicines in Refractory Epilepsy
- A summary of available treatments for refractory epilepsy
- A summary of practice guidelines for treating women with epilepsy: Drug risks to the baby during pregnancy:
- A summary of practice guidelines for treating women with epilepsy: Drug risks and safety during pregnancy:
- The use of AEDs in people with HIV/AIDS
- A summary of treating Infantile Spasms
- Drug therapies for Neurocysticercosis
(Note- link to this article was on the bottom but it’s outdated. Please don’t put back on and archive the article
See a commentary: New guidelines should improve treatment but point out paradox.